Showing 1061-1070 of 1757 results for "".
New in My Practice: Cosmeceuticals/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticalsnew-products-4/23858/Making the Case for Probiotics in Psoriasis Care
https://practicaldermatology.com/topics/psoriasis/making-the-case-for-probiotics-in-psoriasis-care/23702/A literature review reveals much promise, little peril.Wet Wipe Applicators: Exploring the Future of Topical Drug Delivery
https://practicaldermatology.com/topics/psoriasis/wet-wipe-applicators-exploring-the-future-of-topical-drug-delivery/23448/The answer to convenience and adherence could be a wipe.On Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MDBasosquamous Carcinoma: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basosquamous-carcinoma-a-case-series/23815/Basaloid carcinoma, a form of poorly differentiated squamous cell carcinoma, shares histologic similarities with basal cell carcinoma.For Now, the No Surprises Act Applies to All Providers
https://practicaldermatology.com/topics/practice-management/for-now-the-no-surprises-act-applies-to-all-providers/23780/It seems that dermatologists and others providing aesthetic services must comply with new legislation.Musely Aging Repair Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/musely-aging-repair-cream/24033/OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?Establishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million d